Search

everythinglearnresearchcommunity

for

Search:↓

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

Male pattern hair loss could hint at androgens affecting COVID-19 severity.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

AGA linked to worse COVID-19 outcomes in men.

Nursing staff's mental health was affected during the COVID-19 pandemic.

Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

An 84-year-old man developed severe anemia after his first COVID-19 vaccine shot, improved with treatment, and was advised against a second dose.

High-dose vitamin D3 does not improve symptoms or quality of life in COVID-19 patients after one year.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

COVID-19 infection can significantly cause temporary hair loss.

Rehabilitation therapy helped a severe COVID-19 patient regain muscle mass and return to normal life.

Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.

Eating plant-based anti-inflammatories and antioxidants may help manage long-term COVID-19 health issues.

Long-COVID has diverse, long-term health impacts, especially in young people.

A COVID-19 patient had severe and long-lasting skin issues and unusual hair loss.

Most COVID-19 patients in hospitals have androgenetic alopecia, more in men, suggesting a link between androgen sensitivity and severe COVID-19 symptoms.

Certain types of rashes in COVID-19 patients may indicate more severe illness and higher risk of death.

Many severe COVID-19 patients experienced temporary hair loss, but most regrew hair within six months.

Certain skin symptoms in COVID-19 patients may indicate a more severe illness.

The document suggests that more research is needed to confirm if baldness can indicate a higher risk of severe COVID-19 in men.

Men with higher androgen levels may have severe COVID-19 symptoms, but those on antiandrogen therapy are less likely to contract the virus and have milder symptoms. Anti-androgen drugs could potentially treat COVID-19, but more research is needed.

MAIT cells may help fight COVID-19 but also contribute to severe inflammation.

Older men with diabetes were more likely to get severe COVID-19 and needed treatments like antivirals for about 2-3 weeks.

Older men with diabetes were more likely to get severe COVID-19 and needed treatments like antivirals for about 2-3 weeks.

COVID-19 can cause various skin issues, like rashes and lesions, which are more common in younger patients and can be linked to more severe complications.

Monocytes might be linked to hair loss after COVID-19.

Testosterone's effects on COVID-19 are unclear and need more research.